abrdn Healthcare Opportunities Fund Overview
Valuation check: THQ's ROE is -3.29%, above the sector sector average of -5.87%.
Get informed when a big investor buys or sells
+ Follow-3.29%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for THQ is -3.29%. That is above the sector sector average of -5.87%. Investors often review this figure alongside abrdn Healthcare Opportunities Fund's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, THQ currently prints -3.29% for ROE, while the sector average sits near -5.87%. That is roughly 43.9% above the sector mean. Large gaps often invite a closer look at abrdn Healthcare Opportunities Fund's growth, margins, and balance sheet.
Return on Equity shows how effectively abrdn Healthcare Opportunities Fund converts resources into returns. At -3.29%, THQ may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting THQ's ROE (-3.29%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
